Day One Biopharmaceuticals, Inc.DAWNNASDAQ
Loading
Total Costs & Expenses Over TimeContracting
Percentile Rank83
3Y CAGR+24.9%
5Y CAGR+83.4%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
+24.9%/yr
Annual compound
5Y CAGR
+83.4%/yr
Recent deceleration
Percentile
P83
Within normal range
vs 5Y Ago
20.7x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$285.93M-17.9%
2024$348.43M+69.1%
2023$206.06M+40.3%
2022$146.91M+102.0%
2021$72.74M+427.8%
2020$13.78M-7.5%
2019$14.90M-